Observations placeholder
Ranolazine and Ranexa
Identifier
019992
Type of Spiritual Experience
Number of hallucinations: 86
Background
A description of the experience
Ranolazine, sold under the trade name Ranexa , is a drug to treat angina that was first approved in 2006. Ranolazine inhibits the late inward sodium current in heart muscle. Inhibiting that current leads to reductions in elevated intracellular calcium levels.
Side effects
The most common side effects are dizziness (11.8%) and constipation (10.9%) Other side effects include headache and nausea
On Dec, 22, 2016 5,756 people reported to have side effects when taking Ranexa.
Among them, 74 people (1.29%) have Hallucination
On Dec, 29, 2016 3,277 people reported to have side effects when taking Ranolazine.
Among them, 12 people (0.37%) have Hallucination
Time on Ranolazine when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Ranolazine :
| Female | Male | |
| Hallucination | 50.00% | 50.00% |
On Feb, 5, 2016: 379 people reported to have side effects when taking Ranolazine. Among them, 6 people (1.58%) have Death.
On Jan, 24, 2016: 1,712 people reported to have side effects when taking Ranexa. Among them, 65 people (3.80%) have Death.
Time on Ranexa when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 87.50% | 12.50% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |